You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Betamethasone valerate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for betamethasone valerate and what is the scope of patent protection?

Betamethasone valerate is the generic ingredient in eight branded drugs marketed by Novast Labs, Padagis Israel, Taro, Xiromed, Mylan, Cosette, Roaco, Fougera Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Savage Labs, Schering, Actavis Mid Atlantic, Anima, and Teva Pharms, and is included in thirty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for betamethasone valerate. Thirteen suppliers are listed for this compound.

Drug Prices for betamethasone valerate

See drug prices for betamethasone valerate

Recent Clinical Trials for betamethasone valerate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 4
John HarrisPhase 2/Phase 3
Cairo UniversityPhase 4

See all betamethasone valerate clinical trials

Pharmacology for betamethasone valerate
Medical Subject Heading (MeSH) Categories for betamethasone valerate
Paragraph IV (Patent) Challenges for BETAMETHASONE VALERATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
LUXIQ Foam betamethasone valerate 0.12% 020934 1 2007-08-10

US Patents and Regulatory Information for betamethasone valerate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms Inc BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 018865-001 Aug 31, 1983 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pharmaderm BETAMETHASONE VALERATE betamethasone valerate CREAM;TOPICAL 018860-002 Aug 31, 1983 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Perrigo New York BETAMETHASONE VALERATE betamethasone valerate CREAM;TOPICAL 070053-001 Jun 10, 1986 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pharmaderm BETAMETHASONE VALERATE betamethasone valerate LOTION;TOPICAL 018870-001 Aug 31, 1983 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Fougera Pharms Inc BETAMETHASONE VALERATE betamethasone valerate CREAM;TOPICAL 018861-001 Aug 31, 1983 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pharmafair BETAMETHASONE VALERATE betamethasone valerate CREAM;TOPICAL 070485-001 May 29, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Schering VALISONE betamethasone valerate LOTION;TOPICAL 016932-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for betamethasone valerate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan LUXIQ betamethasone valerate AEROSOL, FOAM;TOPICAL 020934-001 Feb 28, 1999 ⤷  Try a Trial ⤷  Try a Trial
Mylan LUXIQ betamethasone valerate AEROSOL, FOAM;TOPICAL 020934-001 Feb 28, 1999 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.